Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
01/2007
01/30/2007US7169905 Modified peptides as therapeutic agents
01/30/2007US7169904 Immunocytokine sequences and uses thereof
01/30/2007US7169897 Adipocyte complement related protein ZACRP3X2
01/30/2007US7169895 Human neuronal nicotinic acetylcholine receptor α6 and β3
01/30/2007US7169893 Human HAC3
01/30/2007US7169891 Human pellino polypeptides
01/30/2007US7169758 Use of hepcidin as a regulator of iron homeostasis
01/30/2007US7169612 Use of EDG2 receptor in an animal model of heart failure
01/30/2007US7169611 Programmable genotoxic agents and uses therefor
01/30/2007US7169603 Nucleic acid; a nucleotide sequence encoding a fusion polypeptide; fusion polypeptides containing alpha -MSH can be used to elicit a variety of biological responses, in vitro and in vivo
01/30/2007US7169601 Apparatus for controlling a chemical reaction; a reaction chamber configured to contain a chemical reaction, a reactant chamber, a channel interconnecting reaction and reactant chambers, a heater, a temperature controller coupled to the heater
01/30/2007US7169597 Nucleotide sequences coding protein for use in the generation of betaine lipid compounds
01/30/2007US7169596 Comprises nucleotide sequences coding adenosine deaminase related protein 1 (ADRP1) for use in identifying modulators for treatment of reproductive, testicular, musclo-skeletal and heart disorders
01/30/2007US7169595 Expressing in a plant cell an expression cassette of a promoter operably linked to a nucleic acid molecule encoding a thermotolerant phytase
01/30/2007US7169593 has both an alpha 2,3- and an alpha 2,8-activity; involved in synthesis of lipooligosaccharide (LOS); genetic engineering
01/30/2007US7169592 Producing optically active amino compounds
01/30/2007US7169589 Highly-expressed and highly active recombinant silicatein enzyme, silicatein isolated from natural source after gene induction
01/30/2007US7169587 LysE proteins; fermentation; animal feeds; dihydrodipicolinate synthases; amino acid biosynthesis
01/30/2007US7169586 DNA coding for the mutant of N-acetylglutamate synthase; amino acid residues are replaced, and feedback inhibition by L-arginine is desensitized
01/30/2007US7169585 Papillomavirus vaccine
01/30/2007US7169583 Nucleic acids; polymerase chain reaction; immobilized to solid support
01/30/2007US7169582 Multifunctional recombinant phycobiliprotein-based fluorescent constructs and phycobilisome display
01/30/2007US7169581 IL-18 receptors
01/30/2007US7169580 Protein having PGE2 synthase activity and use thereof
01/30/2007US7169569 Screening methods using novel Bt toxin receptors from lepidopteran insects
01/30/2007US7169567 Screening for an agonist or an antagonist of PTH receptor activity:
01/30/2007US7169566 Metalloproteinases
01/30/2007US7169565 Isolated antibody that specifically binds to a polypeptide encoded by polynucleotides composed of any polyribonucleotide or polydeoxribonucleotide, which may be unmodified RNA or DNA or modified RNA or DNA
01/30/2007US7169559 Using low density lipoprotein related proteins (LRP) to diagnose, treat and prevent paget's, osteoporosis, cirrhosis and rickets
01/30/2007US7169557 Universal nucleotides for nucleic acid analysis
01/30/2007US7169554 Detection of preferential nucleotide sequences in sample; obtain nucleotide sequences sample, incubate with labeled oligonucleotide, denature, monitor chemiluminescence emission and compare to control
01/30/2007US7169553 2-Azapurine compounds and their use
01/30/2007US7169548 Sperm cell processing and preservation systems
01/30/2007US7169542 Compositions, systems, and methods for imaging
01/30/2007US7169397 equine influenza virus genome segment confers at least one identifying phenotype of a cold-adapted equine influenza virus on the reassortant virus, and genetically-engineered equine influenza viruses, produced through reverse genetics
01/30/2007US7169393 Antigenic peptide fragments of VapA protein, and uses thereof
01/30/2007US7169389 Human CD154 binding molecules and treatment methods
01/30/2007US7169384 Gene for which is located on the short arm of human chromosome 1; gene is directly implicated in colon, kidney and breast cancers
01/30/2007US7169383 Attaching substances to micro-organisms
01/30/2007US7168847 Device for mixing and/or injecting cements
01/30/2007CA2484115C Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases
01/30/2007CA2351553C Transgenic animals
01/30/2007CA2330807C Use of metalloprotinease inhibitors for inducing and/or stimulating growth of hair or hairs and/or for slowing down their loss
01/30/2007CA2284859C Nucleic acid molecule for a human skeletal muscle-specific receptor
01/30/2007CA2210751C Anti-cd6 monoclonal antibodies and their uses
01/30/2007CA2167693C Melanoma-inhibiting protein
01/30/2007CA2166973C Immortalized human fetal osteoblastic cells
01/30/2007CA2151123C Cells with altered betaine catabolism, their preparation and their use, in particular for producing metabolites or enzymes
01/30/2007CA2107537C Inhibition of tumor cell growth by administration of b7-transfected cells
01/30/2007CA1341520C Peptides capable of binding hiv (human immunodeficiency virus) antibodies, their use in diagnosis hiv infections, or for aids vaccination
01/28/2007CA2554107A1 Analytical method and device
01/26/2007CA2553485A1 Multicopy-integration of heterologous genes and expression in methylobacterium
01/25/2007WO2007011941A2 Human anti-b7rp1 neutralizing antibodies
01/25/2007WO2007011771A2 Yield increase in plants overexpressing the mtp genes
01/25/2007WO2007011736A2 Yield increase in plants overexpressing the shsrp genes
01/25/2007WO2007011733A2 Modified frt recombination sites and methods of use
01/25/2007WO2007011681A2 Yield increase in plants overexpressing the hsrp genes
01/25/2007WO2007011670A2 Heterodimeric four helix bundle cytokines
01/25/2007WO2007011625A2 Yield increase in plants overexpressing the accdp genes
01/25/2007WO2007011479A2 Double-stranded rna stabilized in planta
01/25/2007WO2007011312A1 Fish cancer model
01/25/2007WO2007011210A2 Parechovirus, vaccines, medicaments and diagnostic kits
01/25/2007WO2007011202A1 Non-human animal model for cardiovascular disease characterized by a disrupted fibulin-4 gene
01/25/2007WO2007011087A1 A microorganism of enterobacteriacae genus haboring genes associated with l-carintine biosynthesis and methos of producing l-carnitine using the microorganism
01/25/2007WO2007011077A1 Method for extracellular production of target proteins by co-expression of ompf and target proteins
01/25/2007WO2007011074A1 Rna expression vector selective to nervous system cell
01/25/2007WO2007011041A1 Genetically modified antibody composition
01/25/2007WO2007011016A1 Method for production of single-stranded gene tags each having transcription initiation site
01/25/2007WO2007010999A1 Animal in which lipid metabolism and sugar metabolism are modified by krap gene mutation, modification method and modifying agent
01/25/2007WO2007010998A1 High sensitive detection method for target molecule exploiting specific binding and kit for the method
01/25/2007WO2007010892A1 Novel phospholipid processing agent
01/25/2007WO2007010853A1 Method for control of electroporation apparatus
01/25/2007WO2007010840A1 MULTIPLE shRNA EXPRESSION VECTOR
01/25/2007WO2007010740A1 Novel endoribonuclease
01/25/2007WO2007010692A1 Pharmaceutical composition for treatment of inflammatory bowel disease which targets at hvem and btla, and therapeutic method
01/25/2007WO2007010677A1 Pathway display method, information processing device, and pathway display program
01/25/2007WO2007010651A1 Novel proteins and method of using the same
01/25/2007WO2007010628A1 Prophylactic/therapeutic agent for cancer
01/25/2007WO2007010623A1 Novel polypeptide and method for producing the same
01/25/2007WO2007010620A1 Cell transfection array for use in transfection
01/25/2007WO2007010586A1 Hematopoietic stem cell identifier
01/25/2007WO2007010545A1 Rtbv plant promoter and process thereof
01/25/2007WO2007010533A2 Mucosal or enteral administration of biologically active macromolecules
01/25/2007WO2007010293A1 Membrane-translocating peptides
01/25/2007WO2007010287A1 Biological materials and uses thereof
01/25/2007WO2007010283A1 Serine beta-lactamase-like / d-ala carboxypeptidase-like protein
01/25/2007WO2007010243A1 Oligonucleotide library encoding randomised peptides
01/25/2007WO2007010221A2 COMPOSITIONS AND METHODS RELATING TO ORTHOGONAL RIBOSOME mRNA PAIRS
01/25/2007WO2007010133A2 Polypeptides having an activity in the mtbe degradation path and uses thereof
01/25/2007WO2007010040A1 Antigen binding polypeptides against f4 (k88) fimbriae
01/25/2007WO2007009823A1 Overexpression of starch synthase in plants
01/25/2007WO2007009673A1 Chimeric empty viral-like particles derived from the infectious bursal disease virus (ibdv), process for their production and applications
01/25/2007WO2007009359A1 Thymosin beta 4 derivatives and use thereof
01/25/2007WO2007009351A1 A method of secretion expression of lysostaphin in escherichia coli at high level
01/25/2007WO2007009233A2 Peptide-based cytokine vaccines in the treatment of autoimmune and inflammatory diseases
01/25/2007WO2007009181A1 Modification of flavonoid biosynthesis in plants
01/25/2007WO2006131013A3 STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFα
01/25/2007WO2006128885A3 Uses of oligonucleotides stimulatory of the mesenchymal stem cell proliferation
01/25/2007WO2006125977A3 Hybrid interfering rna
01/25/2007WO2006124779A3 Methods for production of chitin and chitosan